Nilotinib, a drug approved to treat leukemia, has been green-lit for more tests to prove its efficacy in treating Alzheimer’s and Parkinson’s. More, here.
Aging in Place Statistics
April 18, 2024
Nilotinib, a drug approved to treat leukemia, has been green-lit for more tests to prove its efficacy in treating Alzheimer’s and Parkinson’s. More, here.
